Ross Warshauer
Private Equity Analyst at 3i US
Ross Warshauer active positions
| Companies | Position | Start | End |
|---|---|---|---|
3i US
 3i US Investment ManagersFinance 3i U.S. is a venture capital firm headquartered in Menlo Park, California. The firm is a subsidiary of 3i Group Plc (LSE: III). | Private Equity Analyst | 01/09/2021 | - |
Career history of Ross Warshauer
Former positions of Ross Warshauer
| Companies | Position | Start | End |
|---|---|---|---|
ten23 Health AG
 ten23 Health AG BiotechnologyHealth Technology ten23 Health AG, founded in 2021, is a Swiss pharmaceutical company that specializes in designing, characterizing, and validating the manufacturing process for stability and preclinical purposes. The company is based in Basel, Switzerland, and has subsidiaries in Switzerland. The company is the partner of choice for the pharmaceutical industry and biotech start-ups for the development, manufacture, and testing of tomorrow ’ s medicines. The company's team of experts can test and evaluate the stability of a vast range of therapeutic modalities. | Director/Board Member | - | - |
Training of Ross Warshauer
| Goizueta Business School-Emory | Undergraduate Degree |
Statistics
International
| United States | 3 |
| Switzerland | 2 |
Operational
| Private Equity Analyst | 1 |
| Undergraduate Degree | 1 |
| Director/Board Member | 1 |
Sectoral
| Finance | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
3i US
3i US Investment ManagersFinance 3i U.S. is a venture capital firm headquartered in Menlo Park, California. The firm is a subsidiary of 3i Group Plc (LSE: III). | Finance |
ten23 Health AG
ten23 Health AG BiotechnologyHealth Technology ten23 Health AG, founded in 2021, is a Swiss pharmaceutical company that specializes in designing, characterizing, and validating the manufacturing process for stability and preclinical purposes. The company is based in Basel, Switzerland, and has subsidiaries in Switzerland. The company is the partner of choice for the pharmaceutical industry and biotech start-ups for the development, manufacture, and testing of tomorrow ’ s medicines. The company's team of experts can test and evaluate the stability of a vast range of therapeutic modalities. | Health Technology |
- Stock Market
- Insiders
- Ross Warshauer
- Experience
